Regardless of the stage of disease, Gleason grade, previous treatments or PSA level at diagnosis or initiation of vitamin D therapy, this paper recently published in the British Journal of Urology International documents significant improvement with Vitamin D. The authors conclude: “Vitamin D therapy is an effective and well tolerated treatment for patients with asymptomatic progressive prostate cancer, and is a useful addition to the therapeutic options.”